SCHEMBL472353

SCHEMBL472353

Clc1ccc(-c2cnco2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 1.00
LTA4H P09960 1/20 0.79
KMT2A Q03164 3/20 0.68
MEN1 O00255 2/20 0.68
PKM P14618 3/20 0.64
LMNA P02545 2/20 0.64
GAA P10253 1/20 0.64
PTK2 Q05397 1/20 0.63
KDM4E B2RXH2 2/20 0.62
NPC1 O15118 2/20 0.62
KEAP1 Q14145 1/20 0.58
HTT P42858 1/20 0.56
CYP3A4 P08684 2/20 0.53
CYP2D6 P10635 2/20 0.53
PSEN1 P49768 1/20 0.53
PSEN2 P49810 1/20 0.53
APH1B Q8WW43 1/20 0.53
NCSTN Q92542 1/20 0.53
APH1A Q96BI3 1/20 0.53
PSENEN Q9NZ42 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28139036 0.89 NOTUM (0.79) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL10768177 0.89 PKM (0.78) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL14027236 0.82 MEN1 (1.00) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL3635051 0.78 PKM (0.64) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL1160951 0.78 PKM (0.64) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL15013310 0.78 LMNA (0.64) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL83171 0.78 PKM (1.00) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL3299412 0.78 PKM (0.64) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL466402 0.78 PKM (0.64) NOTUMLTA4HKMT2AMEN1PKM
SCHEMBL19219054 0.78 PTK2 (0.91) NOTUMLTA4HKMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116751137-B Method for preparing chloro aromatic compound by photo-induced nitroarene denitration chlorination 华中师范大学 2025-03-07 CN disclosed
US-20250011315-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF PRISM MEDICINES, INC. 2025-01-09 US disclosed
CN-114450281-B Inhibitor compounds 辛塞拉治疗私人有限公司 2024-08-16 CN disclosed
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Ikena Oncology, Inc. (US) 2024-07-09 US disclosed
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Ikena Oncology, Inc. (US) 2024-07-09 US disclosed
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof Ikena Oncology, Inc. (US) 2024-07-09 US disclosed
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF ARYL THERAPEUTICS, INC. 2023-09-21 US disclosed
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF ARYL THERAPEUTICS, INC. 2023-09-21 US disclosed
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF ARYL THERAPEUTICS, INC. 2023-09-21 US disclosed
CN-116751137-A Method for preparing chloro aromatic compound by photo-induced nitroarene denitration chlorination 华中师范大学 2023-09-15 CN disclosed
US-10723725-B2 Aminopyridine derivatives as TAM family kinase inhibitors SIGNALCHEM LIFESCIENCES CORPORATION (CA) 2020-07-28 US disclosed
US-20190152965-A1 AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS SIGNALCHEM LIFESCIENCES CORPORATION (CA) 2019-05-23 US disclosed
US-10233176-B2 Aminopyridine derivatives as TAM family kinase inhibitors SIGNALCHEM LIFESCIENCES CORPORATION (CA) 2019-03-19 US disclosed
US-20170022189-A1 AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS SIGNALCHEM LIFESCIENCES CORPORATION (CA) 2017-01-26 US disclosed
EP-2412372-A1 2-Aminooxazole derivatives for use as TRPV1 antagonists for treating i.a. pain, inflammation, neurodegenerative diseases or gastrointestinal diseases Abbott Laboratories (US) 2012-02-01 EP disclosed
US-7998993-B2 TRPV1 antagonists ABBOTT LABORATORIES (US) 2011-08-16 US disclosed
EP-2220059-B1 2-AMINOOXAZOLE DERIVATIVES AS TRPVL ANTAGONISTS USEFUL FOR TREATING PAIN ABBOTT LAB (US) 2011-08-03 EP disclosed
EP-2220059-A1 2-AMINOOXAZOLE DERIVATIVES AS TRPVL ANTAGONISTS USEFUL FOR TREATING PAIN Abbott Laboratories (US) 2010-08-25 EP disclosed
US-20090124666-A1 TRPV1 ANTAGONISTS ABBOTT LABORATORIES (US) 2009-05-14 US disclosed
WO-2009055749-A1 2-AMINOOXAZOLE DERIVATIVES AS TRPVL ANTAGONISTS USEFUL FOR TREATING PAIN ABBOTT LABORATORIES (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011315-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF AHR, ARNT, HCAR1 NOTUM 2628/4885LTA4H 311/4885KMT2A 1031/4885
US-10723725-B2 Aminopyridine derivatives as TAM family kinase inhibitors MAP3K6, MAP3K5, MERTK NOTUM 4384/4885LTA4H 4041/4885KMT2A 559/4885
US-10233176-B2 Aminopyridine derivatives as TAM family kinase inhibitors MAP3K6, MAP3K5, MERTK NOTUM 4384/4885LTA4H 4041/4885KMT2A 559/4885
US-12030876-B2 Aryl hydrocarbon receptor (AHR) agonists and uses thereof AHR, ARNT, HCAR1 NOTUM 2628/4885LTA4H 311/4885KMT2A 1031/4885
US-20230295147-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF AHR, ARNT, HCAR1 NOTUM 2628/4885LTA4H 311/4885KMT2A 1031/4885
US-20090124666-A1 TRPV1 ANTAGONISTS TRPV1, TRPV2, TRPV3 NOTUM 3762/4885LTA4H 274/4885KMT2A 4103/4885
US-20170022189-A1 AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS MAP3K6, MAP3K5, MERTK NOTUM 4384/4885LTA4H 4041/4885KMT2A 559/4885
US-20190152965-A1 AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS MAP3K6, MAP3K5, MERTK NOTUM 4384/4885LTA4H 4041/4885KMT2A 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.